6- (12-Tridecene-1-yl) -2,4-Dihydroxy benzoic acid
Selected Variant
HY-161935
Size: 1 Each
6- (12-Tridecene-1-yl) -2,4-Dihydroxy benzoic acid (Compound 2) exhibits antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin enterococci (VRE) . 6- (12-Tridecene-1-yl) -2,4-Dihydroxy benzoic acid interfers with the integrity and function of the bacterial cell membrane, and affects metabolism in MRSA. 6- (12-Tridecene-1-yl) -2,4-Dihydroxy benzoic acid exhibits anti-inflammatory and anti-infective efficacy, and promotes angiogenesis in mice[1].
Product Specifications
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/6-12-tridecene-1-yl-2-4-dihydroxy-benzoic-acid.html
Smiles
OC1=C(C(O)=O)C(CCCCCCCCCCCC=C)=CC(O)=C1
Molecular Formula
C20H30O4
Molecular Weight
334.45
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD31 / PECAM-1 (158-2B3), CF647 conjugate, 0.1mg/mL
Anti-TrkA/NTRK1 Antibody Picoband® (Dylight488 Conjugate)
PGP9.5 / UchL1 (pan-Neuronal Marker) (rUCHL1/775), CF640R conjugate, 0.1mg/mL
Serum Amyloid A (SAA/2868R), Biotin conjugate, 0.1mg/mL
Anti-NDUFB5 Antibody Picoband®, Dylight550 Conjugate
